Long-term follow-up of reversal of Barrett's esophagus combining endoscopic ablative therapy with acid suppression

Lowe, Adam; Faigel, Douglas; Fennerty, M Brian; Weinstein, Wilfred M; Sampliner, Richard
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS18
Academic Journal
An abstract of the article "Long-term Follow-up of Reversal of Barrett's Esophagus Combining Endoscopic Ablative Therapy With Acid Suppression," by Adam Lowe, Douglas Faigel, M. Brian Fennerty, Wilfred M. Weinstein and Richard Sampliner is presented.


Related Articles

  • Barrett's esophagus and the need for improved diagnostic and prognostic testing. Hoerres, Mike; Critchley-Thorne, Rebecca // MLO: Medical Laboratory Observer;Apr2014, Vol. 46 Issue 4, p32 

    The article discusses Barrett's esophagus (BE) and the importance of better diagnostic and prognostic testing. Data from the National Cancer Institute shows that the fastest growing cancer by incidence in the U.S. is esophageal cancer (EC), in which the major drivers are the increase of people...

  • Controversies in Barrett Esophagus. Dunbar, Kerry B.; Spechler, Stuart Jon // Mayo Clinic Proceedings;Jul2014, Vol. 89 Issue 7, p973 

    Barrett esophagus develops when metaplastic columnar epithelium predisposed to develop adenocarcinoma replaces esophageal squamous epithelium damaged by gastroesophageal reflux disease. Although several types of columnar metaplasia have been described in Barrett esophagus, intestinal metaplasia...

  • Risk Factors for Barrett's Esophagus Compared Between African Americans and Non-Hispanic Whites. Nguyen, Theresa H; Thrift, Aaron P; Ramsey, David; Green, Linda; Shaib, Yasser H; Graham, David Y; El-Serag, Hashem B // American Journal of Gastroenterology;Dec2014, Vol. 109 Issue 12, p1870 

    OBJECTIVES:Esophageal adenocarcinoma is more common among non-Hispanic Whites (NHWs) than African Americans (AAs). It is unclear whether its precursor, Barrett's esophagus (BE), is also less common among AAs, and whether differences in risk factor profiles explain the racial...

  • From Prague to Seattle: Improved Endoscopic Technique and Reporting Improves Outcomes in Patients with Barrett's Esophagus. Brown, J.; Sharma, P. // Digestive Diseases & Sciences;Jan2016, Vol. 61 Issue 1, p4 

    No abstract available.

  • A systematic review of the evidence for radiofrequency ablation for Barrett's esophagus. Semlitsch, Thomas; Jeitler, Klaus; Schoefl, Rainer; Horvath, Karl; Pignitter, Nicole; Harnoncourt, Franz; Siebenhofer, Andrea // Surgical Endoscopy;Dec2010, Vol. 24 Issue 12, p2935 

    Background: Radiofrequency ablation with the HALO system is a new option for the treatment of patients with Barrett's esophagus. This systematic review summarizes the results of all relevant publications on this topic to answer patient-relevant clinical questions and to evaluate the potential...

  • Editorial: Resecting or Burning: What Should We Do With the Remaining Barrett's Epithelium After Successful ER of Neoplasia? Pech, Oliver; Ell, Christian // American Journal of Gastroenterology;Nov2009, Vol. 104 Issue 11, p2693 

    Endoscopic treatment of early Barrett's neoplasia can now be regarded as the treatment of choice in high-grade dysplasia (HGD) and mucosal adenocarcinoma occurring in Barrett's esophagus. Endoscopic resection (ER) is one of the best-validated treatment methods and has the major advantage of...

  • Complete Barrett's Eradication Endoscopic Mucosal Resection: An Effective Treatment Modality for High-Grade Dysplasia and Intramucosal Carcinoma—An American Single-Center Experience. Chennat, Jennifer; Konda, Vani J. A.; Ross, Andrew S.; de Tejada, Alberto Herreros; Noffsinger, Amy; Hart, John; Lin, Shang; Ferguson, Mark K.; Posner, Mitchell C.; Waxman, Irving // American Journal of Gastroenterology;Nov2009, Vol. 104 Issue 11, p2684 

    OBJECTIVES:Complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) is the endoscopic removal of all Barrett's epithelium with the curative intent of eliminating high-grade dysplasia (HGD)/intramucosal carcinoma (IMC) and reducing the risk of metachronous lesion development. We...

  • Treatment of ultralong-segment Barrett’s using focal and balloon-based radiofrequency ablation. Vassiliou, Melina C.; von Renteln, Daniel; Wiener, Daniel C.; Gordon, Stuart R.; Rothstein, Richard I. // Surgical Endoscopy;Apr2010, Vol. 24 Issue 4, p786 

    Endoscopic radiofrequency ablation (ERFA) is being evaluated as definitive treatment for patients with Barrett’s esophagus (BE). Guidelines have yet to be developed for the application of this technology to patients with ultralong-segment BE (ULBE, ≥8 cm). This study reports a...

  • Barrett's Esophagus.  // Current Medical Literature: Gastroenterology;2009, Vol. 28 Issue 1, p18 

    This section presents abstracts of two studies related to Barrett's esophagus including "Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus," and "Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics